Hepatitis B surface antigen (HBsAg) prevalence in Tuvalu
Tuvalu: Hepatitis B surface antigen (HBsAg) prevalence was 1.1% in 2024. ▼ Falling
Latest (2024)
1.1%
Change on year
down 8.3%
World rank
26th
of 194 countries
All-time high
1.3%
in 2015
All-time low
1.1%
in 2024
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Tuvalu, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, hepatitis b surface antigen (hbsag) prevalence in Tuvalu stood at 1.1%. That is the lowest value across all 10 years on record.
Compared with earlier readings it is down 8.3% on the previous year and down 15.4% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Tuvalu peaked at 1.3% in 2015 and was at its lowest, 1.1%, in 2024.
That places Tuvalu 26th out of 194 countries with data for 2024, putting it in the top quarter.
Hepatitis B surface antigen (HBsAg) prevalence in Tuvalu, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 1.3% | — |
| 2016 | 1.2% | -7.7% |
| 2017 | 1.3% | +8.3% |
| 2018 | 1.3% | +0.0% |
| 2019 | 1.3% | +0.0% |
| 2020 | 1.2% | -7.7% |
| 2021 | 1.2% | +0.0% |
| 2022 | 1.2% | +0.0% |
| 2023 | 1.2% | +0.0% |
| 2024 | 1.1% | -8.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1.3% | 1.2% | 1.3% | 5 |
| 2020s | 1.2% | 1.1% | 1.2% | 5 |
Countries ranked near Tuvalu
More health data for Tuvalu
- Heat deaths vs projected death rates, annual growth rate 1.12 % change on previous year (2090)
- Un projection of annual infant deaths, annual growth rate -100 % change on previous year (2095)
- Heat deaths vs projected death rates 985 (2090)
- Un projection of annual infant deaths 0 (2100)
- Age population, age 09, male, interpolated 115 (2025)
- Age population, age 12, female, interpolated 98 (2025)
- Age population, age 11, male, interpolated 111 (2025)
- Age population, age 11, female, interpolated 103 (2025)
- Age population, age 10, male, interpolated 114 (2025)
- Age population, age 09, female, interpolated 106 (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Tuvalu?
- Hepatitis b surface antigen (hbsag) prevalence in Tuvalu was 1.1% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Tuvalu?
- The highest recorded value was 1.3% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Tuvalu?
- The lowest recorded value was 1.1% in 2024.
- How does Tuvalu rank for hepatitis b surface antigen (hbsag) prevalence?
- Tuvalu ranks 26th out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Tuvalu?
- Over the last ten years it is down 15.4%. The long-run trend across the full record is falling.
- Where does this Tuvalu data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).